Literature DB >> 28465309

US drug marketing: how does promotion correspond with health value?

Tyler Greenway1, Joseph S Ross2,3,4.   

Abstract

Mesh:

Substances:

Year:  2017        PMID: 28465309     DOI: 10.1136/bmj.j1855

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  14 in total

1.  Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.

Authors:  Christopher Scott Brunt
Journal:  Health Serv Res       Date:  2018-10-01       Impact factor: 3.402

2.  The relation between promotional spending on drugs and their therapeutic gain: a cohort analysis.

Authors:  Joel Lexchin
Journal:  CMAJ Open       Date:  2017-09-13

3.  Direct-to-Consumer Broadcast Advertisements for Pharmaceuticals: Off-Label Promotion and Adherence to FDA Guidelines.

Authors:  Kristina Klara; Jeanie Kim; Joseph S Ross
Journal:  J Gen Intern Med       Date:  2018-02-26       Impact factor: 5.128

4.  Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019.

Authors:  Anju Murayama; Sae Kamamoto; Hiroaki Saito; Kohki Yamada; Divya Bhandari; Iori Shoji; Hanano Mamada; Moe Kawashima; Erika Yamashita; Eiji Kusumi; Toyoaki Sawano; Binaya Sapkota; Tetsuya Tanimoto; Akihiko Ozaki
Journal:  Int J Environ Res Public Health       Date:  2022-06-16       Impact factor: 4.614

5.  Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.

Authors:  Mohammed W Rahman; Niti U Trivedi; Peter B Bach; Aaron P Mitchell
Journal:  J Natl Compr Canc Netw       Date:  2021-12-29       Impact factor: 12.693

6.  When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.

Authors:  Orna Ehrlich; Laura Wingate; Caren Heller; Inmaculada de Melo-Martin
Journal:  BMC Med Ethics       Date:  2019-12-17       Impact factor: 2.652

7.  Beyond Money: Conscientious Objection in Medicine as a Conflict of Interests.

Authors:  Alberto Giubilini; Julian Savulescu
Journal:  J Bioeth Inq       Date:  2020-05-12       Impact factor: 1.352

8.  Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry's Disclosure UK database, 2015 and 2016 cohorts.

Authors:  Shai Mulinari; Piotr Ozieranski
Journal:  BMJ Open       Date:  2018-10-21       Impact factor: 2.692

9.  Medicines Information and the Regulation of the Promotion of Pharmaceuticals.

Authors:  Teresa Leonardo Alves; Joel Lexchin; Barbara Mintzes
Journal:  Sci Eng Ethics       Date:  2018-05-02       Impact factor: 3.525

10.  Awareness and Attitudes of the Pakistani Population With Regard to Physician-Pharmaceutical Company Interaction: A Cross-Sectional Study.

Authors:  Ali Hassan Gillani; Sumaira Omer; Hafsa Arshad; Wenchen Liu; Chen Chen; Sadia Bashir; Asma Bashir Ahmed; Abubakar Munir; Amna Saeed; Kamran Bashir; Yu Fang
Journal:  Front Pharmacol       Date:  2022-01-07       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.